Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study

Objectives To estimate the prevalence of long COVID symptoms in children with and without a history of SARS-CoV-2 infection and to evaluate factors associated with long COVID.Design A nationwide cross-sectional study.Setting Primary care.Participants 3240 parents of children aged 5–18 with and witho...

Full description

Bibliographic Details
Main Authors: Robert Hoffman, Zachi Grossman, Joseph Azuri, Limor Adler, Moran Israel, Ilan Yehoshua, Arnon Shahar, Miri Mizrahi Reuveni
Format: Article
Language:English
Published: BMJ Publishing Group 2023-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/2/e064155.full
_version_ 1797900204477775872
author Robert Hoffman
Zachi Grossman
Joseph Azuri
Limor Adler
Moran Israel
Ilan Yehoshua
Arnon Shahar
Miri Mizrahi Reuveni
author_facet Robert Hoffman
Zachi Grossman
Joseph Azuri
Limor Adler
Moran Israel
Ilan Yehoshua
Arnon Shahar
Miri Mizrahi Reuveni
author_sort Robert Hoffman
collection DOAJ
description Objectives To estimate the prevalence of long COVID symptoms in children with and without a history of SARS-CoV-2 infection and to evaluate factors associated with long COVID.Design A nationwide cross-sectional study.Setting Primary care.Participants 3240 parents of children aged 5–18 with and without SARS-CoV-2 infection completed an online questionnaire (11.9% response rate); 1148 and 2092 with/without a history of infection, respectively.Primary and secondary outcome measures Primary outcome was the prevalence of long COVID symptoms in children with/without a history of infection. Secondary outcomes were the factors associated with the presence of long COVID symptoms and with failure to return to baseline health status in children with a history of infection including gender, age, time from illness, symptomatic illness and vaccine status.Results Most long COVID symptoms were more prevalent in children with a history of SARS-CoV-2 infection: headaches (211 (18.4%) vs 114 (5.4%), p<0.001), weakness (173 (15.1%) vs 70 (3.3%), p<0.001), fatigue (141 (12.3%) vs 133 (6.4%), p<0.001) and abdominal pain (109 (9.5%) vs 79 (3.8%), p<0.001). Most long COVID symptoms in children with a history of SARS-CoV-2 infection were more prevalent in the older age group (12–18) compared with the younger age group (5–11). Some symptoms were more prevalent in children without a history of SARS-CoV-2 infection, including attention problems with school malfunctioning (225 (10.8%) vs 98 (8.5%), p=0.05), stress (190 (9.1%) vs 65 (5.7%), p<0.001), social problems (164 (7.8%) vs 32 (2.8%)) and weight changes (143 (6.8%) vs 43 (3.7%), p<0.001).Conclusion This study suggests that the prevalence of long COVID symptoms in children with a history of SARS-CoV-2 infection might be higher and more prevalent in adolescents than in young children. Some of the symptoms, mainly somatic symptoms, were more prevalent in children without a history of SARS-CoV-2 infection, highlighting the impact of the pandemic itself rather than the infection.
first_indexed 2024-04-10T08:42:20Z
format Article
id doaj.art-26ab94dc7efa4a5e934edb1a28eddd4e
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-04-10T08:42:20Z
publishDate 2023-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-26ab94dc7efa4a5e934edb1a28eddd4e2023-02-22T23:30:09ZengBMJ Publishing GroupBMJ Open2044-60552023-02-0113210.1136/bmjopen-2022-064155Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional studyRobert Hoffman0Zachi Grossman1Joseph Azuri2Limor Adler3Moran Israel4Ilan Yehoshua5Arnon Shahar6Miri Mizrahi Reuveni7Department of Family Medicine, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, IsraelHealth Division, Maccabi Healthcare Services, Tel Aviv, IsraelDepartment of Family Medicine, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, IsraelDepartment of Family Medicine, Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, IsraelHealth Division, Maccabi Healthcare Services, Tel Aviv, IsraelHealth Division, Maccabi Healthcare Services, Tel Aviv, IsraelHealth Division, Maccabi Healthcare Services, Tel Aviv, IsraelHealth Division, Maccabi Healthcare Services, Tel Aviv, IsraelObjectives To estimate the prevalence of long COVID symptoms in children with and without a history of SARS-CoV-2 infection and to evaluate factors associated with long COVID.Design A nationwide cross-sectional study.Setting Primary care.Participants 3240 parents of children aged 5–18 with and without SARS-CoV-2 infection completed an online questionnaire (11.9% response rate); 1148 and 2092 with/without a history of infection, respectively.Primary and secondary outcome measures Primary outcome was the prevalence of long COVID symptoms in children with/without a history of infection. Secondary outcomes were the factors associated with the presence of long COVID symptoms and with failure to return to baseline health status in children with a history of infection including gender, age, time from illness, symptomatic illness and vaccine status.Results Most long COVID symptoms were more prevalent in children with a history of SARS-CoV-2 infection: headaches (211 (18.4%) vs 114 (5.4%), p<0.001), weakness (173 (15.1%) vs 70 (3.3%), p<0.001), fatigue (141 (12.3%) vs 133 (6.4%), p<0.001) and abdominal pain (109 (9.5%) vs 79 (3.8%), p<0.001). Most long COVID symptoms in children with a history of SARS-CoV-2 infection were more prevalent in the older age group (12–18) compared with the younger age group (5–11). Some symptoms were more prevalent in children without a history of SARS-CoV-2 infection, including attention problems with school malfunctioning (225 (10.8%) vs 98 (8.5%), p=0.05), stress (190 (9.1%) vs 65 (5.7%), p<0.001), social problems (164 (7.8%) vs 32 (2.8%)) and weight changes (143 (6.8%) vs 43 (3.7%), p<0.001).Conclusion This study suggests that the prevalence of long COVID symptoms in children with a history of SARS-CoV-2 infection might be higher and more prevalent in adolescents than in young children. Some of the symptoms, mainly somatic symptoms, were more prevalent in children without a history of SARS-CoV-2 infection, highlighting the impact of the pandemic itself rather than the infection.https://bmjopen.bmj.com/content/13/2/e064155.full
spellingShingle Robert Hoffman
Zachi Grossman
Joseph Azuri
Limor Adler
Moran Israel
Ilan Yehoshua
Arnon Shahar
Miri Mizrahi Reuveni
Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study
BMJ Open
title Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study
title_full Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study
title_fullStr Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study
title_full_unstemmed Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study
title_short Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study
title_sort long covid symptoms in israeli children with and without a history of sars cov 2 infection a cross sectional study
url https://bmjopen.bmj.com/content/13/2/e064155.full
work_keys_str_mv AT roberthoffman longcovidsymptomsinisraelichildrenwithandwithoutahistoryofsarscov2infectionacrosssectionalstudy
AT zachigrossman longcovidsymptomsinisraelichildrenwithandwithoutahistoryofsarscov2infectionacrosssectionalstudy
AT josephazuri longcovidsymptomsinisraelichildrenwithandwithoutahistoryofsarscov2infectionacrosssectionalstudy
AT limoradler longcovidsymptomsinisraelichildrenwithandwithoutahistoryofsarscov2infectionacrosssectionalstudy
AT moranisrael longcovidsymptomsinisraelichildrenwithandwithoutahistoryofsarscov2infectionacrosssectionalstudy
AT ilanyehoshua longcovidsymptomsinisraelichildrenwithandwithoutahistoryofsarscov2infectionacrosssectionalstudy
AT arnonshahar longcovidsymptomsinisraelichildrenwithandwithoutahistoryofsarscov2infectionacrosssectionalstudy
AT mirimizrahireuveni longcovidsymptomsinisraelichildrenwithandwithoutahistoryofsarscov2infectionacrosssectionalstudy